We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+14.13%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$24.4B
AUM Growth
+$627M
Cap. Flow
-$540M
Cap. Flow %
-2.21%
Top 10 Hldgs %
48.29%
Holding
168
New
24
Increased
37
Reduced
33
Closed
24

Top Buys

Rank Stock Value
1
ETHA
iShares Ethereum Trust ETF
ETHA
+$221M
2
WAB icon
Wabtec
WAB
+$177M
3
K
Kellanova
K
+$173M
4
NSC icon
Norfolk Southern
NSC
+$171M
5
EXEL icon
Exelixis
EXEL
+$139M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.53B
2
HES
Hess
HES
+$804M
3
IQV icon
IQVIA
IQV
+$530M
4
LBRDK icon
Liberty Broadband Class C
LBRDK
+$421M
5
ANSS
Ansys
ANSS
+$350M

Sector Composition

Rank Sector Weight
1 Healthcare 33.14%
2 Technology 11.51%
3 Financials 9.33%
4 Communication Services 4.99%
5 Industrials 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIVN icon
101
LivaNova
LIVN
$4.2B
$314K ﹤0.01%
6,000
– –
IONS icon
102
Ionis Pharmaceuticals
IONS
$9.4B
$314K ﹤0.01%
+4,800
New +$234K
COR icon
103
Cencora
COR
$61.2B
$313K ﹤0.01%
1,000
– –
CAPR icon
104
Capricor Therapeutics
CAPR
$237M
$296K ﹤0.01%
41,000
– –
TVTX icon
105
Travere Therapeutics
TVTX
$5.78B
$287K ﹤0.01%
12,000
– –
MRUS
106
DELISTED
Merus
MRUS
$282K ﹤0.01%
+3,000
New +$195K
GRFS
107
Grifois
GRFS
$5.4B
$279K ﹤0.01%
28,000
– –
ASND icon
108
Ascendis Pharma A/S
ASND
$16.8B
$278K ﹤0.01%
1,400
– –
SBRA icon
109
Sabra Healthcare REIT
SBRA
$5.37B
$261K ﹤0.01%
14,000
– –
SRRK icon
110
Scholar Rock
SRRK
$6.44B
$261K ﹤0.01%
7,000
– –
NUVL
111
DELISTED
Nuvalent
NUVL
$259K ﹤0.01%
3,000
-147,000
-98% -$11.6M
MMSI icon
112
Merit Medical Systems
MMSI
$5.32B
$250K ﹤0.01%
3,000
– –
COGT icon
113
Cogent Biosciences
COGT
$7.24B
$244K ﹤0.01%
17,000
– –
VCYT icon
114
Veracyte
VCYT
$3.8B
$240K ﹤0.01%
+7,000
New +$201K
GMED icon
115
Globus Medical
GMED
$11.2B
$229K ﹤0.01%
4,000
-206,000
-98% -$11.9M
ANNAW
116
AleAnna Inc Warrant
ANNAW
$8.06M
$226K ﹤0.01%
990,000
– –
GEHC icon
117
GE HealthCare
GEHC
$32.4B
$225K ﹤0.01%
3,000
-1,319,000
-100% -$98.4M
MIRM icon
118
Mirum Pharmaceuticals
MIRM
$6.14B
$220K ﹤0.01%
+3,000
New +$191K
URGN icon
119
UroGen Pharma
URGN
$2.29B
$219K ﹤0.01%
+11,000
New +$198K
HR icon
120
Healthcare Realty
HR
$6.84B
$216K ﹤0.01%
12,000
– –
TWST icon
121
Twist Bioscience
TWST
$7.25B
$215K ﹤0.01%
7,650
– –
GKOS icon
122
Glaukos
GKOS
$10.6B
$212K ﹤0.01%
2,600
– –
RARE icon
123
Ultragenyx Pharmaceutical
RARE
$2.55B
$211K ﹤0.01%
7,000
-891,000
-99% -$26.7M
ICLR icon
124
Icon
ICLR
$12.7B
$210K ﹤0.01%
+1,200
New +$201K
IMVT icon
125
Immunovant
IMVT
$8.25B
$193K ﹤0.01%
12,000
– –
3 4
5
6 7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Farallon Capital Management held 168 positions worth $24.4B, up 2.6% from $23.8B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management's Q3 2025 filing shows 24 new, 37 increased, 33 reduced and 24 closed positions. Its largest new stake was iShares Ethereum Trust ETF: 7,450,730 shares worth $235M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.53B.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q3 2025 buy was iShares Ethereum Trust ETF: 7,450,730 shares worth $235M.
  • Farallon Capital Management added most to Wabtec in Q3 2025, an estimated $177M increase.
  • Farallon Capital Management's biggest Q3 2025 reduction was IQVIA, cutting an estimated $530M.
  • Farallon Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q3 2025, selling an estimated $3.53B.
  • Farallon Capital Management's ten largest holdings make up 48% of its $24.4B portfolio in Q3 2025.
  • Farallon Capital Management opened 24 new positions and closed 24 in Q3 2025.
  • Farallon Capital Management's portfolio value rose 2.6% quarter-over-quarter to $24.4B.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.